Commentary: Coronary artery bypass grafting surgery alone is not the only way!

[1]  R. Josephson,et al.  Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction. , 2021, The Journal of thoracic and cardiovascular surgery.

[2]  I. Piña,et al.  CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. , 2019, JACC. Heart failure.

[3]  P. Kolh,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial , 2019, The Lancet.

[4]  C. Pepine,et al.  Medical Therapy for Heart Failure Caused by Ischemic Heart Disease. , 2019, Circulation research.

[5]  D. Malenka,et al.  Comparative effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in a real‐world Surgical Treatment for Ischemic Heart Failure trial population , 2018, The Journal of thoracic and cardiovascular surgery.

[6]  R. McKelvie,et al.  2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. , 2017, The Canadian journal of cardiology.

[7]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[8]  C. O'connor,et al.  Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.

[9]  B. Brent,et al.  Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.

[10]  Lippincott Williams Wilkins,et al.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.